Because CCL14 can recruit tumor infiltrating immune cells (TIIC) such as CD4 + and CD8 + T cells, neutrophils, and B cells, it has been associated with amplifying anti-tumor immunity in hepatocellular carcinoma26 and lung adenocarcinoma27. The gene discussed is CD8A; the disease is neoplasm.